FMC Corp vs Synopsys, Inc. — how do they compare? FMC Corp trades at $8.89 (market cap $1.41B), while Synopsys, Inc. trades at $502 (market cap $96.33B). The key difference: Synopsys, Inc. is far larger — about 68.3× FMC Corp's market cap, and FMC Corp pays a 3.52% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Synopsys, Inc. for 71 Days on average.
| FMC | SNPS | |
|---|---|---|
Market Cap | $1.41B | $96.33B |
Volume | 4,507,459 | 1,631,837 |
Sector | Basic Materials | Technology |
52-Week High | $30.63 | $534.56 |
52-Week Low | $8.44 | $367.70 |
Typical Hold Time | 68 Days | 71 Days |
Enterprise Value | $5.22B | $103.56B |
Dividend Yield | 3.52% | — |
Signals from Pluang's Aura AI — not financial advice
FMC trades at $8.92, down 1.22% on the day, with a bearish technical signal and negative profitability metrics including a net income margin of -84.83% and ROE of -91.47% for 2025. Recent news highlights regulatory progress with rimisoxafen in Brazil and a minority equity investment from Tessenderlo Group. Cash flow trends show volatility, with 2025 net cash flow positive at $227.20M but driven by financing activities as operating cash flow was negative.
The outlook is challenged by significant losses and high debt, though analyst consensus suggests upside with a $14.60 price target. Key risks include sustained negative margins, industry cyclicality, and execution of deleveraging plans. The stock presents a high-risk opportunity contingent on operational turnaround and debt reduction success.
Synopsys (SNPS) trades at $497.75, down 1.47% on the day but remains near recent highs following strong quarterly earnings beats and bullish investor sentiment driven by AI partnerships. The stock shows a bullish technical trend with moving averages supporting upside, while RSI levels indicate overbought conditions. Recent news highlights multi-year agreements with OpenAI and Amazon Web Services, fueling growth expectations beyond traditional EDA markets.
The outlook is positive with a consensus price target of $572.54, reflecting 15% upside potential, though high valuation multiples (P/E of 87.73) and integration risks from the Ansys acquisition warrant caution. Revenue growth is projected to accelerate, supported by AI-driven demand, but margin compression and competitive pressures pose medium-term risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →